Sfoglia per Autore
p63 and p73 transactivate differentiation gene promoters in human keratinocytes
2000-01-01 DE LAURENZI, V; Rossi, A; Terrinoni, A; Barcaroli, D; Levrero, M; Costanzo, A; Knight, Ra; Guerrieri, P; Melino, G.
Mitogen-activated kinase kinase kinase 1 regulates T cell receptor- and CD28-mediated signaling events which lead to NF-kappaB activation.
2000-01-01 Tuosto, L; Costanzo, A; Guido, F; Marinari, B; Vossio, S; Moretti, F; Levrero, M; Piccolella, E
Anziano e dermatologia
2001-01-01 Costanzo, A; Bianchi, L; Ribuffo, A
Prostaglandine e Leucotrieni
2001-01-01 Carboni, I; Costanzo, A; Chimenti, S
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody.
2001-01-01 Soda, R; Costanzo, A; Cantonetti, M; Orlandi, A; Bianchi, L; Chimenti, S
Induction of gene expression via activator protein-1 in the ascorbate protection against UV-induced damage.
2001-01-01 Catani, Mv; Rossi, A; Costanzo, A; Sabatini, S; Levrero, M; Melino, G; Avigliano L. Biochem J., 2001 May 15; 356(Pt, 1):77-85.
La terapia classica dell’orticaria.
2001-01-01 Costanzo, A; Chimenti, S; Bianchi, L
Ascorbate up-regulates MLH1 (Mut L homologue-1) and p73: implications for the cellular response to DNA damage. . 2002 Jun 1;364(Pt 2):441-7
2002-01-01 Catani, Mv; Costanzo, A; Savini, I; Levrero, M; DE LAURENZI, V; Wang, Jy; Melino, G; Avigliano, L.
DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes
2002-01-01 Costanzo, A; Merlo, P; Pediconi, N; Fulco, M; Sartorelli, V; Cole, Pa; Fontemaggi, G; Fanciulli, M; Schiltz, L; Blandino, G; Balsano, C; Levrero, M
Prevalence and genomic variability of transfusion transmitted virus in Italian cryptogenic chronic liver disease and healthy blood donors.
2002-01-01 Artini, M; Cariani, E; Almerighi, C; Fulco, M; Rossini, A; Pietropaolo, L; Stivali, G; Montalto, G; Caratozzolo, M; Girelli, G; Grimali, E; Costanzo, A; Levrero, M; Balsano, C
DN-p73 is activated after DNA damage in a p53-dependent manner to regulate p53-induced cell cycle arrest
2002-01-01 Vossio, S; Palescandolo, E; Pediconi, N; Moretti, F; Balsano, C; Levrero, M; Costanzo, A
Physical interaction with human tumor-derived p53 mutants inhibits p63 activities
2002-01-01 Strano, S; Fontemaggi, G; Costanzo, A; Rizzo, Mg; Monti, O; Baccarini, A; Del, Sal; G, ; Levrero, M; Sacchi, A; Oren, M; Blandino, G.
A myogenic differentiation checkpoint activated by genotoxic stress
2002-01-01 Puri, Pl; Bhakta, K; Wood, Ld; Costanzo, A; Zhu, J; Wang, Jy
Vav cooperates with CD28 to induce NF-kappa B activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1
2002-01-01 Barbara, M; Costanzo, A; Antonella, V; Michel, F; Mangino, G; Acuto, O; Levrero, M; Piccolella, E; Tuosto, L
Endothelial activation by angiotensin II through NFkappaB and p38 pathways: Involvement of NFkappaB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin. . 2003 Jun;195(3):402-10
2003-01-01 Costanzo, A; Moretti, F; Burgio, Vl; Bravi, C; Guido, F; Levrero, M; Puri, Pl.
Differential regulation of E2F1 apoptotic target genes in response to DNA damage
2003-01-01 Pediconi, N; Ianari, A; Costanzo, A; Belloni, L; Gallo, R; Cimino, L; Porcellini, A; Screpanti, I; Balsano, C; Alesse, E; Gulino, A; Levrero, M.
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients
2003-01-01 Bianchi, L; Costanzo, A; Carnpione, E; Nistico, S; Chimenti, S
Actinic keratosis treated with an immune response modifier: a case report of six patients
2003-01-01 Bianchi, L; Campione, E; Marulli, Gc; Costanzo, A; Chimenti, S
Adenosine deaminase, a key enzyme in DNA precursors control, is a new p73 target
2003-01-01 Tullo, A; Mastropasqua, G; Bourdon, Jc; Centonze, P; Gostissa, M; Costanzo, A; Levrero, M; DEL SAL, G; Saccone, C; Sbisa, E.
High-dose intravenous immunoglobulin for severe drug reactions: Efficacy in toxic epidermal necrolysis
2003-01-01 Campione, E; Marulli, Gc; Carrozzo, Am; Chimenti, Ms; Costanzo, A; Bianchi, L
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
p63 and p73 transactivate differentiation gene promoters in human keratinocytes | 1-gen-2000 | DE LAURENZI, V; Rossi, A; Terrinoni, A; Barcaroli, D; Levrero, M; Costanzo, A; Knight, Ra; Guerrieri, P; Melino, G. | |
Mitogen-activated kinase kinase kinase 1 regulates T cell receptor- and CD28-mediated signaling events which lead to NF-kappaB activation. | 1-gen-2000 | Tuosto, L; Costanzo, A; Guido, F; Marinari, B; Vossio, S; Moretti, F; Levrero, M; Piccolella, E | |
Anziano e dermatologia | 1-gen-2001 | Costanzo, A; Bianchi, L; Ribuffo, A | |
Prostaglandine e Leucotrieni | 1-gen-2001 | Carboni, I; Costanzo, A; Chimenti, S | |
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody. | 1-gen-2001 | Soda, R; Costanzo, A; Cantonetti, M; Orlandi, A; Bianchi, L; Chimenti, S | |
Induction of gene expression via activator protein-1 in the ascorbate protection against UV-induced damage. | 1-gen-2001 | Catani, Mv; Rossi, A; Costanzo, A; Sabatini, S; Levrero, M; Melino, G; Avigliano L. Biochem J., 2001 May 15; 356(Pt, 1):77-85. | |
La terapia classica dell’orticaria. | 1-gen-2001 | Costanzo, A; Chimenti, S; Bianchi, L | |
Ascorbate up-regulates MLH1 (Mut L homologue-1) and p73: implications for the cellular response to DNA damage. . 2002 Jun 1;364(Pt 2):441-7 | 1-gen-2002 | Catani, Mv; Costanzo, A; Savini, I; Levrero, M; DE LAURENZI, V; Wang, Jy; Melino, G; Avigliano, L. | |
DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes | 1-gen-2002 | Costanzo, A; Merlo, P; Pediconi, N; Fulco, M; Sartorelli, V; Cole, Pa; Fontemaggi, G; Fanciulli, M; Schiltz, L; Blandino, G; Balsano, C; Levrero, M | |
Prevalence and genomic variability of transfusion transmitted virus in Italian cryptogenic chronic liver disease and healthy blood donors. | 1-gen-2002 | Artini, M; Cariani, E; Almerighi, C; Fulco, M; Rossini, A; Pietropaolo, L; Stivali, G; Montalto, G; Caratozzolo, M; Girelli, G; Grimali, E; Costanzo, A; Levrero, M; Balsano, C | |
DN-p73 is activated after DNA damage in a p53-dependent manner to regulate p53-induced cell cycle arrest | 1-gen-2002 | Vossio, S; Palescandolo, E; Pediconi, N; Moretti, F; Balsano, C; Levrero, M; Costanzo, A | |
Physical interaction with human tumor-derived p53 mutants inhibits p63 activities | 1-gen-2002 | Strano, S; Fontemaggi, G; Costanzo, A; Rizzo, Mg; Monti, O; Baccarini, A; Del, Sal; G, ; Levrero, M; Sacchi, A; Oren, M; Blandino, G. | |
A myogenic differentiation checkpoint activated by genotoxic stress | 1-gen-2002 | Puri, Pl; Bhakta, K; Wood, Ld; Costanzo, A; Zhu, J; Wang, Jy | |
Vav cooperates with CD28 to induce NF-kappa B activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1 | 1-gen-2002 | Barbara, M; Costanzo, A; Antonella, V; Michel, F; Mangino, G; Acuto, O; Levrero, M; Piccolella, E; Tuosto, L | |
Endothelial activation by angiotensin II through NFkappaB and p38 pathways: Involvement of NFkappaB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin. . 2003 Jun;195(3):402-10 | 1-gen-2003 | Costanzo, A; Moretti, F; Burgio, Vl; Bravi, C; Guido, F; Levrero, M; Puri, Pl. | |
Differential regulation of E2F1 apoptotic target genes in response to DNA damage | 1-gen-2003 | Pediconi, N; Ianari, A; Costanzo, A; Belloni, L; Gallo, R; Cimino, L; Porcellini, A; Screpanti, I; Balsano, C; Alesse, E; Gulino, A; Levrero, M. | |
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients | 1-gen-2003 | Bianchi, L; Costanzo, A; Carnpione, E; Nistico, S; Chimenti, S | |
Actinic keratosis treated with an immune response modifier: a case report of six patients | 1-gen-2003 | Bianchi, L; Campione, E; Marulli, Gc; Costanzo, A; Chimenti, S | |
Adenosine deaminase, a key enzyme in DNA precursors control, is a new p73 target | 1-gen-2003 | Tullo, A; Mastropasqua, G; Bourdon, Jc; Centonze, P; Gostissa, M; Costanzo, A; Levrero, M; DEL SAL, G; Saccone, C; Sbisa, E. | |
High-dose intravenous immunoglobulin for severe drug reactions: Efficacy in toxic epidermal necrolysis | 1-gen-2003 | Campione, E; Marulli, Gc; Carrozzo, Am; Chimenti, Ms; Costanzo, A; Bianchi, L |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile